Chlorpromazine induces apoptosis in activated human lymphoblasts: A mechanism supporting the induction of drug-induced lupus erythematosus?

Arthritis and Rheumatism

Volumn 43, Issue 9, 2000, Pages 1994-2004

  Hieronymus, Thomas ^a   Grötsch, Philipp ^a   Blank, Norbert ^a   Grunke, Mathias ^a   Capraru, Dorin ^b   Geiler, Thomas ^a   Winkler, Silke ^a   Kalden, Joachim R ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORPROMAZINE; HYDRALAZINE; ISONIAZID; PROCAINAMIDE; QUINIDINE;

APOPTOSIS; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; HUMAN; HUMAN CELL; LYMPHOCYTE; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; TOXICITY TESTING;

EID: 0033680356     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(200009)43:9<1994::AID-ANR10>3.0.CO;2-7     Document Type: Article

References (47)

1. The apoptosis-1/Fas protein in human systemic lupus erythematosus
2. Bcl-2 expression is unaltered in unfractionated peripheral blood mononuclear cells in patients with systemic lupus erythematosus
3. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus
4. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases
5. Decreased rescue from apoptosis through γ(c)-chain cytokine signaling in PHA lymphoblasts deriving from SLE patients with high inflammatory activity
6. Current trends in drug-induced autoimmunity
7. Drug-induced lupus erythematosus
8. Predisposing factors in sulphasalazine-induced systemic lupus erythematosus
9. HLA-DR7 in association with chlorpromazine-induced lupus anticoagulant (LA)
10. Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupus like disease in syngeneic mice
11. Mechanisms of drug-induced lupus. IV. Comparison of procainamide and hydralazine with analogs in vitro and in vivo
12. Autoimmunity caused by disruption of central T cell tolerance: A murine model of drug-induced lupus
13. A metabolite of the lupus-inducing drug procainamide prevents anergy induction in T cell clones
14. Mechanisms of drug-induced lupus. I. Cloned Th2 cells modified with DNA methylation inhibitors in vitro cause autoimmunity in vivo
15. New concepts in the pathogenesis of drug-induced lupus
16. Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity
17. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils
18. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry
19. A standardized approach to PCR-based semiquantitation of multiple cytokine gene transcripts from small cell samples
20. Inhibition by chlorpromazine of lymphokine-specific mRNA expression in human thymocytes
21. Comparison of the immunosuppressive effects of cyclosporine, lipid-soluble anesthetics, and calmodulin antagonists: Response to exogenous interleukin-2
22. Differential role for IL-2 and IL-15 in the inhibition of apoptosis in short term activated human lymphocytes
23. Induction of apoptosis in short term-activated lymphocytes (PHA blasts) after cytokine withdrawal is Fas/APO1-independent, involves proteases and sphingomyelinase
24. Sphingosine-1-phosphate in cell growth and cell death
25. Sphingosine-1-phosphate: A prototype of a new class of second messengers
26. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate
27. Caspase-dependent ceramide production in Fas- and HLA class I-mediated peripheral T cell apoptosis
28. Increased spontaneous in vitro apoptosis in double negative T cells of humans with a fas/apo-1 mutation
29. Potential therapeutic efficacy of inhibitors of human phospholipase A2 in septic shock
30. 2+ channels in smooth muscle from rat vas deferens
31. Irreversible oxidative inactivation of protein kinase C by photosensitive inhibitor calphostin C
32. 2 causes TNF resistance in human leukemic cells
33. Features of apoptotic cells measured by flow cytometry
34. Clinical significance of plasma chlorpromazine levels
35. The presence of 7-hydroxychlorpromazine in CSF of chlorpromazine-treated patients
36. Drug distribution between blood and brain as a determinant of anti-psychotic drug effects
37. Concentrations of chlorpromazine and two of its active metabolites in plasma and cerebrospinal fluid of psychotic patients treated with fixed doses
38. Correlation between plasma chlorpromazine and its metabolites and clinical ratings in patients with acute relapse of schizophrenic and paranoid psychosis
39. The possible role of metabolites in therapeutic response to chlorpromazine treatment
40. Phagocyte recognition of cells undergoing apoptosis
41. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
42. Immunosuppressive effects of apoptotic cells
43. Recognition of apoptotic cells by human macrophages: Inhibition by a monocyte/macrophage-specific monoclonal antibody
44. Posttranslational protein modifications, apoptosis, and the bypass of tolerance to autoantigens
45. Histone-specific Th0 and Th1 clones derived from systemic lupus erythematosus patients induce double-stranded DNA antibody production
46. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus